tradmap

SMTI Sanara MedTech Inc.

$32.19 +0.00%

Data as of close

Healthcare · Orthopedic, Prosthetic & Surgical Appliances & Supplies

Sanara MedTech Inc. (SMTI) is a healthcare company in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry, with a market capitalization of $296 million. Shares last traded at $32.19, 8.9% below their 52-week high. Over the past year the stock is up 10.1%. Net profit margin is -29.2%, below the peer median of 5.3%. Revenue grew 19.0% year over year.

Market Cap
$296M
Shares Out
9.2M
EPS (TTM)
-$3.72
P/E (TTM)*
—
P/S Ratio
2.69
P/B Ratio
37.23
Dividend / Share
—
Dividend Yield
—
52-Week High
$35.34
52-Week Low
$16.05
Volume (venue)
4,530
Avg Vol (3m, venue)
7,702.19

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Performance

1W
-2.13%
1M
-8.08%
3M
-5.43%
6M
+62.49%
YTD
+37.92%
1Y
+10.13%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
20.59
SMA (50)
$34.43
SMA (200)
$25.63
Price vs SMA50
-6.50%
Price vs SMA200
+25.58%
ATR (14)
$0.54

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$110M
Net Income
-$32M
Gross Margin
93.0%
Operating Margin
7.7%
Net Margin
-29.2%
Return on Equity
-403.0%
Return on Assets
-46.3%
Current Ratio
2.58
Debt / Equity
5.85
Revenue Growth (YoY)
+19.0%

Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-06-30. Source: SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 -$0.05 2026-08-11
Q1 2026 $0.05 2026-05-12
Q4 2025 (derived) -$0.32 2026-03-24
FY 2025 -$4.36 2026-03-24
Q3 2025 -$3.40 2025-11-12
Q2 2025 -$0.23 2025-08-13

Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.

Full earnings history →

Orthopedic, Prosthetic & Surgical Appliances & Supplies peers

SMTI vs 14 industry peers (Orthopedic, Prosthetic & Surgical Appliances & Supplies), by market cap. Data as of close

P/S vs peers
2.69 / 2.65 med
+2% premium
Net margin vs peers
-29.2% / 5.3% med
below median
1–14 of 14
ISRGIntuitive Surgical$152.8B51.6613.1925.5%+0.84%
EWEdwards Lifesciences$54.9B54.618.4315.4%+2.09%
STESteris$22.5B27.993.7313.3%-0.93%
ZBHZimmer Biomet$18.5B22.952.189.5%-0.26%
ALGNAlign Technology$10.8B26.042.6010.0%-1.68%
MSAMsa Safety Inc$6.7B22.183.3315.0%-6.82%
ESTAEstablishment Labs Holdings Inc.$1.8B—7.44-15.8%+0.52%
CDRECadre Holdings, Inc.$1.3B36.921.945.3%-1.44%
ENOVEnovis Corp$1.2B—0.52-48.0%+1.24%
AVRAnteris Technologies Global Corp.$546M—243.43—-2.95%
SMTISanara MedTech Inc.$296M—2.69-29.2%+0.00%
INGNInogen Inc$187M—0.61-8.1%+2.33%
LAKELAKELAND INDUSTRIES INC$89M—0.46-14.0%-0.11%
NTRBNutriBand Inc.$77M———+1.03%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.